Exchange: NASDAQ·Updated 07:37 PM EDT
PYPD logo

PYPD Polypid Ltd

$4.96
$0.17
(3.47%)
Today
Closed $5.07
$0.11
(2.17%)
After Hours
EarningsNov 11
Mkt Cap$99.53M
Vol60,179.00

About PYPD

PolyPid Ltd. operates as a phase 3 biopharma company. Its proprietary PLEX technology pairs with medications, enables precise delivery of drugs at effective release rates, over pre-determined durations ranging from several days to months. The firm's product candidates are designed to address unmet medical needs by delivering active pharmaceutical ingredients, or APIs, locally at predetermined release rates and durations over extended periods ranging from days to several months. The company was founded by Noam Emanuel on February 28, 2008 and is headquartered in Petach Tikva, Israel.
66

Bullish Sentiment

How do you feel about PYPD?

Finnish_boy
$PYPD There will be ATH before FDA decision. I think $5.8 - $6.5 If approva,l heading to $10 by the end of year. Next year $20.
5
PaulWalter
$PYPD Crazy price. So close to approval, partner, money in the bank, great partnership deal. This should make minimum 100m first year US only. Worth 15 right now. So many biotechs floundering with XBI up. Strange.
1
3
robbied61
$PYPD fyi i bought yesterday me and some friends got all we wanted between 5.30 and 5.32
1
3
robbied61
$PYPD manufacturing facility inspection end of Oct press release in early November according to company
1
Finnish_boy
$PYPD Nothing new.. MAA submission in October.. mgt hinted ealier maybe not in this month.. H1 October likely. Waiting game (PDUFA)
1
2
lelXYpics
$PYPD we have 1352 watchers; 30% increase within a few months. Visibility is critical towards the PDUFA.
5
BigPajamas
$PYPD as someone with an unreasonable amount of my portfolio in this... I fucking love days like this lmao.
5
TomiGurArie
$PYPD resistance here is something beyond my understanding 2 months ahead PDUFA. with those chances for approval, with that deal and partnership, and most importantly with dplex technology just doesn't make sense to believe that this is fully priced. Which leads me to believe that no one knows about this ticker...
1
1
Finnish_boy
$PYPD Remember, scalable delivery platform very valuable. D-PLEX100 just starting point! You repeat, repeat, repeat. Look at Camurus AB, went from 250M market cap to 3.75B today.. 15X !! Polypid 100M at the moment. SKYROCKETING AHEAD.
4
pandodark
$PYPD Company is doing everything right. Gonna be a banger. One of the biggest surgical breakthrus in years. Can’t believe this isn’t $20 min. Market cap is going to explode upon approval in 2 months.
3
robbied61
$PYPD ok finish i believe ur conclusion are acurate and very well thought out how ever the crrent price leaves me some doubt we should be over 7 right as we speak i believe the company lacks mkt savy and exposure and mgt is aloof to this issue. I have spoken to mgt multiple times and they have focused on there fundamentals and i believe stock price is irrelevant to them they have everything they need in there eyes and unfortunately i believe. They are right!!
3
EscapePlan
$PYPD my AI friend estimates risk of CRL at 15-20%. So even if you are really cautious you have a 4 in 5 chance of doubling your money in the next two months
1
PaulNipkow
$PYPD There will be info if a visit occured ... Because the official FDA registers are delayed for pending drugs, institutional traders use alternative "smoke signals" to figure out if PolyPid's factory in Israel was audited and whether they received a 483: • Tracking the FOIA Request Logs: Instead of waiting for a 483 to be published, track the FOIA Submission Log. If you see an entry where an investment firm or specialized law firm suddenly requests "Inspection records for PolyPid facility, September 2026," it is a definitive sign that the FDA audit team just left the building.
2
zampy
$PYPD This company has all the ingredients only thing holding this back damn frigging 4.50 warrants 7.5m of them Stapled/ unstapled supply has to be coming from there. Frustrating stock. No reward.
1
lelXYpics
$PYPD $PYPD between the two Ph3s, they probably already manufactured 2000 doses. The manufacturing process has matured.
PaulWalter
$PYPD if approved, we’ve got to be looking at 100m revenue first year with Azurity ready to go. 60> efficacy, easy to administer. Administration important, I learnt from HRTX. Could be 15 in June, within reason.
PaulWalter
$PYPD I’ve been in and out of this for years . Ready to pull the trigger again. Looks so close. When will fda inspect manufacturing facility?
Mattt6
$PYPD this stock has low amount of followers here and little chatter on social media. This is probably the trend until FDA decision. It’s not a bad thing, necessarily, but it’s the most likely trend. It has no bearing on the decision itself
callmepsychic
$PYPD should we expect this downward momentum until, corrrect me if I’m wrong, the pdfu date on November 28? Bought in a little too early looks like
newtraderlookingforhope
$PYPD Hey are you still here? SLS yielded me a healthy profit this year so I am just trying to see where I can out some. I feel this ticker is ridiculous on how nuch it has been pinned as it gets close to PDUFA. No balance sheet issues, just straight binary.

Advertisement|Remove ads.